Pfizer chief medical officer honored by HBA
NEW YORK — The chief medical officer at one of the largest drug makers in the world has been named "woman of the year" by the Healthcare Businesswomen’s Association.
Freda Lewis-Hall, Pfizer’s chief medical officer, will be honored at the HBA’s 22nd annual "Woman of the Year" luncheon in May.
Lewis-Hall’s 30-year career in healthcare leadership includes roles in direct patient care, academics, media, government, pharmaceuticals and biotechnology.
HBA president Deborah Coogan Seltzer said that Lewis-Hall "sets the tone" for those in the industry for her "long-standing commitment to the social responsibilities of healthcare leadership — especially in making sure that people have the education and understanding to make the best healthcare decisions."
Mylan’s generic Sular gets FDA OK
PITTSBURGH — The Food and Drug Administration has approved a generic hypertension treatment made by Mylan.
Mylan announced the approval Friday of nisoldipine extended-release tablets in the 8.5-mg, 17-mg, 25.5-mg and 34-mg strengths. The drug is a generic version of Shionogi Pharma’s Sular, which had sales of about $103 million during the 12-month period ended in September 2010, according to IMS Health.
Mylan was the first company to file a regulatory approval application for the drug and is thus entitled to 180 days in which to compete directly with the branded version under the provisions of the Hatch-Waxman Act of 1984, the law that created a regulatory approval pathway for generic pharmaceutical drugs.
Italo Pennella named VP pharmacy at ECRM
NEW YORK — A former Albertsons executive has been named the newest VP pharmacy at ECRM.
Italo Pennella, a licensed pharmacist, will utilize his insight on the pharmaceutical supply chain as ECRM’s newest executive. At Albertsons, Pennella’s career spanned more than 10 years, which included oversight of all brand manufacturer relationships. Prior to joining ECRM, Pennella most recently served as associated director of trade for Otsuka and Schering-Plough/Organon.
“We are excited to have Pennella as part of our team and look forward to his support and insights to our rapidly growing pharmacy events. His diverse background will benefit him in his role to expand all areas of pharmacy at ECRM,” said Charlie Bowlus, ECRM CEO and founder.